DDDR-27. A PATIENT-DERIVED DRUG SCREENING PLATFORM PREDICTS RESPONSE TO TEMOZOLOMIDE AND IDENTIFIES POTENTIAL NEW TREATMENTS FOR GLIOBLASTOMA

DDDR-27. A PATIENT-DERIVED DRUG SCREENING PLATFORM PREDICTS RESPONSE TO TEMOZOLOMIDE AND IDENTIFIES POTENTIAL NEW TREATMENTS FOR GLIOBLASTOMA

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro-oncology (Charlottesville, Va.) Va.), 2022-11, Vol.24 (Supplement_7), p.vii104-vii105
Hauptverfasser: Ntafoulis, Ioannis, Kleijn, Anne, Posthoorn-Verheul, Cassandra, Koolen, Stijn L W, Kers, Trisha, den Hollander, Chelsea W J, Ju, Jie, Li, Yunlei, Stubbs, Andrew P, Dirven, Clemens M F, Leenstra, Sieger, Lamfers, Martine L M
Format: Artikel
Sprache:eng
Schlagworte:
Drug Discovery, Drug Resistance
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page vii105
container_issue Supplement_7
container_start_page vii104
container_title Neuro-oncology (Charlottesville, Va.)
container_volume 24
creator Ntafoulis, Ioannis
Kleijn, Anne
Posthoorn-Verheul, Cassandra
Koolen, Stijn L W
Kers, Trisha
den Hollander, Chelsea W J
Ju, Jie
Li, Yunlei
Stubbs, Andrew P
Dirven, Clemens M F
Leenstra, Sieger
Lamfers, Martine L M
description
doi_str_mv 10.1093/neuonc/noac209.392
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9660398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_9660398</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1422-f71fa718aeb558894cd1f6ad7f66bb76d1f02a5a5600766459b18837116fddd53</originalsourceid><addsrcrecordid>eNpVkd9KwzAUh4soOKcv4FVeoDNpl7S9EeKS1UDblDZT8Cak_3SytaN1gg_hO9u5IXh1fucczgeHz7JuEZwhGLh3bb3v2vKu7UzpwGDmBs6ZNUHYcW3sE3L-mx3bx8i7tK6G4R1CB2GCJtY3YyyzHW8GKEipEjxRNuOZeOIMsGwVgnyRcZ6IJARpRNVSZjFIM87EQuUg43kqk5wDJYHisXyRkYwF44AmDIw1UWIpeA5SqQ6ZRiDhz0BlnKp4HORgxIEwEvIhormSMb22LhqzGeqbU51aqyVXi0c7kqFY0Mgu0Xz8o_FQYzzkm7rA2PeDeVmhhpjKawgpCo-MHXQMNphA6BEyx0GBfN_1ECJNVVXYnVr3R-5uX2zrqqzbj95s9K5fb03_pTuz1v837fpNv3afOiAEuoE_ApwjoOy7Yejr5u8WQX0woo9G9MmIHo24Pw8FeLQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>DDDR-27. A PATIENT-DERIVED DRUG SCREENING PLATFORM PREDICTS RESPONSE TO TEMOZOLOMIDE AND IDENTIFIES POTENTIAL NEW TREATMENTS FOR GLIOBLASTOMA</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Ntafoulis, Ioannis ; Kleijn, Anne ; Posthoorn-Verheul, Cassandra ; Koolen, Stijn L W ; Kers, Trisha ; den Hollander, Chelsea W J ; Ju, Jie ; Li, Yunlei ; Stubbs, Andrew P ; Dirven, Clemens M F ; Leenstra, Sieger ; Lamfers, Martine L M</creator><creatorcontrib>Ntafoulis, Ioannis ; Kleijn, Anne ; Posthoorn-Verheul, Cassandra ; Koolen, Stijn L W ; Kers, Trisha ; den Hollander, Chelsea W J ; Ju, Jie ; Li, Yunlei ; Stubbs, Andrew P ; Dirven, Clemens M F ; Leenstra, Sieger ; Lamfers, Martine L M</creatorcontrib><identifier>ISSN: 1522-8517</identifier><identifier>EISSN: 1523-5866</identifier><identifier>DOI: 10.1093/neuonc/noac209.392</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Drug Discovery, Drug Resistance</subject><ispartof>Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii104-vii105</ispartof><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660398/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660398/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Ntafoulis, Ioannis</creatorcontrib><creatorcontrib>Kleijn, Anne</creatorcontrib><creatorcontrib>Posthoorn-Verheul, Cassandra</creatorcontrib><creatorcontrib>Koolen, Stijn L W</creatorcontrib><creatorcontrib>Kers, Trisha</creatorcontrib><creatorcontrib>den Hollander, Chelsea W J</creatorcontrib><creatorcontrib>Ju, Jie</creatorcontrib><creatorcontrib>Li, Yunlei</creatorcontrib><creatorcontrib>Stubbs, Andrew P</creatorcontrib><creatorcontrib>Dirven, Clemens M F</creatorcontrib><creatorcontrib>Leenstra, Sieger</creatorcontrib><creatorcontrib>Lamfers, Martine L M</creatorcontrib><title>DDDR-27. A PATIENT-DERIVED DRUG SCREENING PLATFORM PREDICTS RESPONSE TO TEMOZOLOMIDE AND IDENTIFIES POTENTIAL NEW TREATMENTS FOR GLIOBLASTOMA</title><title>Neuro-oncology (Charlottesville, Va.)</title><subject>Drug Discovery, Drug Resistance</subject><issn>1522-8517</issn><issn>1523-5866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkd9KwzAUh4soOKcv4FVeoDNpl7S9EeKS1UDblDZT8Cak_3SytaN1gg_hO9u5IXh1fucczgeHz7JuEZwhGLh3bb3v2vKu7UzpwGDmBs6ZNUHYcW3sE3L-mx3bx8i7tK6G4R1CB2GCJtY3YyyzHW8GKEipEjxRNuOZeOIMsGwVgnyRcZ6IJARpRNVSZjFIM87EQuUg43kqk5wDJYHisXyRkYwF44AmDIw1UWIpeA5SqQ6ZRiDhz0BlnKp4HORgxIEwEvIhormSMb22LhqzGeqbU51aqyVXi0c7kqFY0Mgu0Xz8o_FQYzzkm7rA2PeDeVmhhpjKawgpCo-MHXQMNphA6BEyx0GBfN_1ECJNVVXYnVr3R-5uX2zrqqzbj95s9K5fb03_pTuz1v837fpNv3afOiAEuoE_ApwjoOy7Yejr5u8WQX0woo9G9MmIHo24Pw8FeLQ</recordid><startdate>20221114</startdate><enddate>20221114</enddate><creator>Ntafoulis, Ioannis</creator><creator>Kleijn, Anne</creator><creator>Posthoorn-Verheul, Cassandra</creator><creator>Koolen, Stijn L W</creator><creator>Kers, Trisha</creator><creator>den Hollander, Chelsea W J</creator><creator>Ju, Jie</creator><creator>Li, Yunlei</creator><creator>Stubbs, Andrew P</creator><creator>Dirven, Clemens M F</creator><creator>Leenstra, Sieger</creator><creator>Lamfers, Martine L M</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20221114</creationdate><title>DDDR-27. A PATIENT-DERIVED DRUG SCREENING PLATFORM PREDICTS RESPONSE TO TEMOZOLOMIDE AND IDENTIFIES POTENTIAL NEW TREATMENTS FOR GLIOBLASTOMA</title><author>Ntafoulis, Ioannis ; Kleijn, Anne ; Posthoorn-Verheul, Cassandra ; Koolen, Stijn L W ; Kers, Trisha ; den Hollander, Chelsea W J ; Ju, Jie ; Li, Yunlei ; Stubbs, Andrew P ; Dirven, Clemens M F ; Leenstra, Sieger ; Lamfers, Martine L M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1422-f71fa718aeb558894cd1f6ad7f66bb76d1f02a5a5600766459b18837116fddd53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Drug Discovery, Drug Resistance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ntafoulis, Ioannis</creatorcontrib><creatorcontrib>Kleijn, Anne</creatorcontrib><creatorcontrib>Posthoorn-Verheul, Cassandra</creatorcontrib><creatorcontrib>Koolen, Stijn L W</creatorcontrib><creatorcontrib>Kers, Trisha</creatorcontrib><creatorcontrib>den Hollander, Chelsea W J</creatorcontrib><creatorcontrib>Ju, Jie</creatorcontrib><creatorcontrib>Li, Yunlei</creatorcontrib><creatorcontrib>Stubbs, Andrew P</creatorcontrib><creatorcontrib>Dirven, Clemens M F</creatorcontrib><creatorcontrib>Leenstra, Sieger</creatorcontrib><creatorcontrib>Lamfers, Martine L M</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ntafoulis, Ioannis</au><au>Kleijn, Anne</au><au>Posthoorn-Verheul, Cassandra</au><au>Koolen, Stijn L W</au><au>Kers, Trisha</au><au>den Hollander, Chelsea W J</au><au>Ju, Jie</au><au>Li, Yunlei</au><au>Stubbs, Andrew P</au><au>Dirven, Clemens M F</au><au>Leenstra, Sieger</au><au>Lamfers, Martine L M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DDDR-27. A PATIENT-DERIVED DRUG SCREENING PLATFORM PREDICTS RESPONSE TO TEMOZOLOMIDE AND IDENTIFIES POTENTIAL NEW TREATMENTS FOR GLIOBLASTOMA</atitle><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle><date>2022-11-14</date><risdate>2022</risdate><volume>24</volume><issue>Supplement_7</issue><spage>vii104</spage><epage>vii105</epage><pages>vii104-vii105</pages><issn>1522-8517</issn><eissn>1523-5866</eissn><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/neuonc/noac209.392</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1522-8517
ispartof Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii104-vii105
issn 1522-8517
1523-5866
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9660398
source Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Drug Discovery, Drug Resistance
title DDDR-27. A PATIENT-DERIVED DRUG SCREENING PLATFORM PREDICTS RESPONSE TO TEMOZOLOMIDE AND IDENTIFIES POTENTIAL NEW TREATMENTS FOR GLIOBLASTOMA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A34%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DDDR-27.%20A%20PATIENT-DERIVED%20DRUG%20SCREENING%20PLATFORM%20PREDICTS%20RESPONSE%20TO%20TEMOZOLOMIDE%20AND%20IDENTIFIES%20POTENTIAL%20NEW%20TREATMENTS%20FOR%20GLIOBLASTOMA&rft.jtitle=Neuro-oncology%20(Charlottesville,%20Va.)&rft.au=Ntafoulis,%20Ioannis&rft.date=2022-11-14&rft.volume=24&rft.issue=Supplement_7&rft.spage=vii104&rft.epage=vii105&rft.pages=vii104-vii105&rft.issn=1522-8517&rft.eissn=1523-5866&rft_id=info:doi/10.1093/neuonc/noac209.392&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_9660398%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true